Stay updated on Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.

Latest updates to the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page
- Check2 days agoChange DetectedThe revision label on the page updated from v3.6.0 to v3.6.2. This reflects a small maintenance update to the site's underlying system rather than changes to study content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now states that no participants are being recruited. Additional help and navigation sections were added (e.g., How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header was updated, while the previous Intervention / Treatment variant was removed.SummaryDifference0.2%

- Check23 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5. This appears to be a minor maintenance update to the page’s versioning, with no visible changes to study data or user-facing content.SummaryDifference0.0%

- Check45 days agoChange DetectedA new revision label, v3.5.4, has been added. The previous label v3.5.3 has been removed.SummaryDifference0.0%

- Check66 days agoChange DetectedThe ClinicalTrials.gov page footer revision label was updated from v3.5.2 to v3.5.3, indicating a site/version update without changing the displayed study details.SummaryDifference0.0%

- Check73 days agoChange DetectedOno Pharmaceutical Co., Ltd. and Revision: v3.5.2 were added, while Ono Pharmaceutical Co. Ltd and Revision: v3.5.0 were removed.SummaryDifference0.0%

Stay in the know with updates to Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.